2023_Jun_Connect_in_Pharma_skyscraper1

advanced search
2023 June Inhalation HW Boston
Dr Dave Seaward
Projects Director
3P Innovation

Is this your profile?

About

Dave Seaward, PhD, is a chartered engineer and 3P innovation’s founding director. He has a first degree in electrical and mechanical engineering and a control theory PhD (applying servo motors to automation). Dr Seaward’s 35-year career has focused on developing custom automation for numerous industries, including the pharmaceutical and MedTech sectors. He is named inventor on over 20 patents including Unilever’s pyramid teabag patent, which is included in the UK Patent Office book “Inventing the 20th Century”. Many of Dr Seaward’s projects have included powder or liquid
dispensing, and recently he worked on numerous dry powder inhalers, drug eluting and injectable drug delivery projects.

Contributions

INJECTION
DRIVERS FOR CHANGE IN ASEPTIC AUTOMATION
Dave Seaward and David Phasey discuss the factors that have led to recent growth in aseptic automation within the pharmaceutical industry.

More contributions

INDUSTRIALISATION
MANAGING RISKS & COSTS FOR SEAMLESS SCALE-UP & SMOOTH COMMERCIALISATION
Today’s drug delivery industry is seeing shifting thought in a number of areas, one of which is the move towards design for manufacture. Simon Strothers and Dave Seaward both of 3P innovation, discuss a “better way” for developing drug delivery devices, highlighting design for manufacture, critical quality concerns and mandraulic prototyping.
EXPERT VIEW
CHOOSING THE RIGHT DOSATOR FOR DPI DOSING
Jamie Clayton, Rajeev Dattani and Dave Seaward discuss the operation of dosators for reliable and accurate filling of DPI capsules and blisters.
PULMONARY
A NOVEL POWDER FILLING TECHNOLOGY TO REDUCE DEVELOPMENT COSTS & TIMELINES
Simon Strothers and Dave Seaward discuss the evolution of filling technology in the inhaled world, including a new technology and approach to filling which offers significant advantages over conventional filling systems.
Top